Daily News Podcast

A hidden bonus for rivaroxaban?


 

Bleeding from rivaroxaban may help diagnose some GI and GU cancers. Also today, a review by the FDA supports the safety of nuplazid, arthritis is prevalent in older adults with any degree of depression, and growth in overdose deaths is exponential.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

Cardiovascular risk with diclofenac
MDedge Hematology and Oncology
Baloxavir, oseltamivir similar for influenza
MDedge Hematology and Oncology
New guidelines on prophylaxis for cancer-related immunosuppresion
MDedge Hematology and Oncology
CDC opens Emergency Operations Center in advance of Hurricane Florence
MDedge Hematology and Oncology
Urine drug screens show improper medication use
MDedge Hematology and Oncology
Alarming rate of diabetes medication discontinuations
MDedge Hematology and Oncology
Troubling MRI changes and pediatric hypertension
MDedge Hematology and Oncology
Behavioral intervention in obese adults
MDedge Hematology and Oncology
Black patients miss out on promising cancer drugs
MDedge Hematology and Oncology
What you should know about celiac disease
MDedge Hematology and Oncology